Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Search projects and results

Results 1 - 10 of 24
Order by: Results/page:
12 3 > 
Sensing and controlling single molecules by novel electrical, mechanical and optical methods with applications to nanobiotechnology
ID: QLK3-CT-2001-00278
Start date: 2002-01-01, End date: 2004-12-31
This project concerns controlling and sensing single bio molecules by means of Nan electrodes and laser spectroscopy. First, the molecular position and orientation between systems of Nan electrodes will be sensed and controlled. The Nan electrodes will also act as "antennas" i...
Programme: FP5-LIFE QUALITY
Record Number: 64192
Last updated on: 2012-06-12
Preclinical evaluation of delivery systems for neuroprotective gene therapy in neurodegenerative diseases.
ID: QLK3-CT-1999-00702
Start date: 2000-03-01, End date: 2004-03-01
The long-term objective is to provide a comprehensive pre-clinical background for neuroprotective therapies, using gene therapy delivery systems developed by European biotechnology companies, in patients with neurodegenerative diseases. Experimental studies have pointed to th...
Programme: FP5-LIFE QUALITY
Record Number: 52107
Last updated on: 2005-04-12
Novel in vitro testing platforms based on intra-and extracellular sensing
ID: QLK3-CT-2001-00244
Start date: 2002-01-01, End date: 2004-12-31
The goal of the project is to develop new in-vitro platforms for pharmaceutical screening based on animal or human cells grown on microelectrode arrays enabling simultaneous monitoring of extra- and intracellular levels of key metabolites (e.g., NO and super oxide) by using op...
Programme: FP5-LIFE QUALITY
Record Number: 64198
Last updated on: 2005-04-12
Novel bioprocesses for hemicellulose up-grading
ID: QLK3-CT-1999-00080
Start date: 2000-02-01, End date: 2003-01-31
BIO-HUG aims at securing the competitiveness of European starch industry by engineering new integrated bioprocesses. Steam pre-treatment and enzymatic hydrolysis of starch derived hemicellulose containing by-products will be optimised with respect to sugar yield and ferment ab...
Programme: FP5-LIFE QUALITY
Record Number: 51508
Last updated on: 2005-04-12
Antidiuresis using short-acting vasopressin-v2-receptor agonists as a new treatment strategy of urinary incontinence and voiding disorders
ID: QLK3-CT-2001-00987
Start date: 2001-09-01, End date: 2004-08-31
More than forty million middle-aged and elderly EU-citizens suffer from urinary voiding disorders, including incontinence and frequent nightly urination, due to multifactor diseases. The overall goal is to establish temporary antidiuresis as an efficient new therapeutic strate...
Programme: FP5-LIFE QUALITY
Record Number: 59017
Last updated on: 2005-04-12
Cliniporator: a new adaptative generator for dna electrotransfer in vivo for gene therapy
ID: QLK3-CT-1999-00484
Start date: 2000-02-01, End date: 2003-07-31
The objective is to improve the knowledge about nutrient utilization during and after periods of malnutrition. The focus is put on optimal strategies for human nutrition, but the investigations will be performed with animals as models. It will include comparative measurements ...
Programme: FP5-LIFE QUALITY
Record Number: 51516
Last updated on: 2005-04-12
Medical end-of-live decisions: attitudes and practices in 6 european countries
ID: QLG6-CT-2000-00859
Start date: 2000-10-01, End date: 2003-09-30
Advances in medical technology and the emphasis in modern society on patient autonomy have, among other factors, increased the scientific and societal debate on the role of medicine at the end of life. In this project, the incidence, characteristics and attitudes concerning en...
Programme: FP5-LIFE QUALITY
Record Number: 54274
Last updated on: 2005-04-12
Fragrance chemical allergy: a major environmental and consumer health problem in europe
ID: QLK4-CT-1999-01558
Start date: 2000-02-01, End date: 2003-03-31
Sensitivity to fragrance ingredients is acknowledged as a common and clinically important problem in Europe. At least 1-2% of the general population is allergic (delayed hypersensitivity) to standard indicators of fragrance chemical allergy, which makes contact sensitisation t...
Programme: FP5-LIFE QUALITY
Record Number: 52810
Last updated on: 2005-04-12
Microalgae as cell factories for chemical and biochemical products
ID: QLK3-CT-2002-02132
Start date: 2003-02-01, End date: 2006-01-31
There is increasing interest throughout Europe in alternative methods of obtaining chemical and biochemical products. Scientists are increasingly turning to micro algae as a natural source of many useful products. They also have many other useful properties, e.g. as a food sou...
Programme: FP5-LIFE QUALITY
Record Number: 68982
Last updated on: 2005-04-12
Development of a genomic dna bank of iga nephropathy (igan) patients and family members. new trends in genetics for the early diagnosis of familial igan
ID: QLG1-CT-2000-00464
Start date: 2000-10-01, End date: 2003-12-31
IgA nephropathy (IgAN) is the most relevant for of glomerulonephritis in Europe. It occurs in early adulthood and leads to end stage renal disease in more than 25%of patients after 10 years from the onset of the disease. Thus, considering that young adults need periodic dialys...
Programme: FP5-LIFE QUALITY
Record Number: 54569
Last updated on: 2005-04-12
12 3 > 
List retrieved on: 2017-11-20
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top